These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8646231)

  • 1. Mononeuritis multiplex in systemic lupus erythematosus: response to pulse intravenous cyclophosphamide.
    Martinez-Taboada VM; Alonso RB; Armona J; Fernandez-Sueiro JL; Gonzalez Vela C; Rodriguez-Valverde V
    Lupus; 1996 Feb; 5(1):74-6. PubMed ID: 8646231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature.
    Grimbacher B; Huber M; von Kempis J; Kalden P; Uhl M; Köhler G; Blum HE; Peter HH
    Br J Rheumatol; 1998 Sep; 37(9):1023-8. PubMed ID: 9783772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mononeuritis multiplex associated with necrotizing vasculitis (author's transl)].
    Cartier L; Quintana J; Vergara F
    Rev Med Chil; 1980 Jun; 108(6):519-26. PubMed ID: 6110230
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial.
    Galindo-Rodríguez G; Aviña-Zubieta JA; Pizarro S; Díaz de León V; Saucedo N; Fuentes M; Lavalle C
    Am J Med; 1999 Jan; 106(1):65-9. PubMed ID: 10320119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasculitic neuropathy: profile of twenty patients.
    Singhal BS; Khadilkar SV; Gursahani RD; Surya N
    J Assoc Physicians India; 1995 Jul; 43(7):459-61. PubMed ID: 8713216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide.
    Martin-Suarez I; D'Cruz D; Mansoor M; Fernandes AP; Khamashta MA; Hughes GR
    Ann Rheum Dis; 1997 Aug; 56(8):481-7. PubMed ID: 9306871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for cutaneous arteritis patients with mononeuritis multiplex and elevated C-reactive protein.
    Kawakami T; Okudaira A; Okano T; Takeuchi S; Kimura S; Soma Y; Ishizu A; Arimura Y; Kobayashi S; Ozaki S
    J Dermatol; 2013 Dec; 40(12):955-61. PubMed ID: 24303898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke due to vasculitis.
    Kott HS
    Prim Care; 1979 Dec; 6(4):771-89. PubMed ID: 43988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
    Igarashi T; Igarashi T; Shimizu A; Itoh Y
    J Nippon Med Sch; 2013; 80(5):396-400. PubMed ID: 24189359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mononeuritis multiplex and vasculitis. Association with anti-neutrophil cytoplasmic autoantibody.
    Kafka SP; Condemi JJ; Marsh DO; Leddy JP
    Arch Neurol; 1994 Jun; 51(6):565-8. PubMed ID: 8198467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recurrent abdominal colic, myalgia and mononeuritis multiplex].
    Folwaczny C; Scheller A; Schenk F; Hallfeldt K; Klauser A; Schenkirsch G; Seibold C; Pickardt CR
    Z Gastroenterol; 1998 Sep; 36(9):839-45. PubMed ID: 9795413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necroqizing enterocolitis with pneumatosis intestinalis in systemic lupus erythematosus and polyarteritis.
    Kleinman P; Meyers MA; Abbott G; Kazam E
    Radiology; 1976 Dec; 121(3 Pt. 1):595-8. PubMed ID: 10599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of polyarteritis nodosa in the course of inactive systemic lupus erythematosus.
    Vivancos J; Soler-Carrillo J; Ara-del Rey J; Font J
    Lupus; 1995 Dec; 4(6):494-5. PubMed ID: 8749575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of intermittent, intravenous cyclophosphamide in severe systemic lupus erythematosus.
    Martinelli R; Pereira LJ; Santos ES; Rocha H
    Nephron; 1996; 74(2):313-7. PubMed ID: 8893147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
    Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
    Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful treatment of intravenous cyclophosphamide pulse therapy for systemic lupus erythematosus complicated with steroid-resistant hemolytic anemia].
    Tokunaga M; Saito K; Nakatsuka K; Nakayamada S; Nakano K; Tsujimura S; Ota T; Tanaka Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2003 Oct; 26(5):304-9. PubMed ID: 14635405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose intravenous cyclophosphamide therapy in severe SLE.
    D'Cruz D
    Lupus; 2002; 11(7):403-4. PubMed ID: 12195779
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasculitic neuropathy in panarteritis nodosa: clinical and ultrastructural findings.
    Bussone G; La Mantia L; Frediani F; Tredici G; Petruccioli Pizzini MG
    Ital J Neurol Sci; 1986 Apr; 7(2):265-9. PubMed ID: 2873112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1 antitrypsin deficiency and systemic necrotizing vasculitis.
    Fortin PR; Fraser RS; Watts CS; Esdaile JM
    J Rheumatol; 1991 Oct; 18(10):1613-6. PubMed ID: 1684994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
    Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
    Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.